Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for growth factor receptor
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
- L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Most Relevant Literature
- MUC1 promotes glioblastoma progression and TMZ resistance by stabilizing EGFRvIII.
- Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice.
- PD1 Expression in EGFRvIII-Directed CAR T Cell Infusion Product for Glioblastoma Is Associated with …
- Flagellin synergistically enhances anti-tumor effect of EGFRvIII peptide in a glioblastoma-bearing m…
- PARK7 maintains the stemness of glioblastoma stem cells by stabilizing epidermal growth factor recep…
Most Relevant Clinical Trials
- Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth…
- A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene A…
- A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-s…
- Molecular Imaging of Epidermal Growth Factor Receptor in Colorectal Neoplasia Using Confocal Laser E…
- Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor…
